<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27105" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Bacterial Pharyngitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Harberger</surname>
            <given-names>Seneca</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goldin</surname>
            <given-names>Jennifer</given-names>
          </name>
          <aff>Wright State University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Graber</surname>
            <given-names>Matthew</given-names>
          </name>
          <aff>Magnolia Regional Health Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Seneca Harberger declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jennifer Goldin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Graber declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27105.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Respiratory viral pathogens predominate as culprits of infectious pharyngitis, characterized by inflammation of the pharynx leading to a sore throat. However, bacterial etiologies hold clinically important significance. Despite most cases being self-limited, identifying bacterial pharyngitis is imperative to avert potential long-term complications like rheumatic fever and glomerulonephritis. Among bacterial causes, Group A &#x003b2;-hemolytic&#x000a0;<italic toggle="yes">Streptococcus</italic>&#x000a0;or&#x000a0;<italic toggle="yes">Streptococcus pyogenes</italic><italic toggle="yes">&#x000a0;</italic>is the most common bacterial cause.&#x000a0;</p>
        <p>Viral and bacterial pharyngitis have overlapping symptoms.&#x000a0;Thus, clinicians should not depend solely on physical examination to establish the diagnosis of group A &#x003b2;-hemolytic streptococcal infection. Rapid antigen detection, nucleic acid amplification testing, or throat culture is necessary to confirm the diagnosis. The presence of a runny nose, cough, mouth ulcers, a viral exanthem, conjunctivitis, or hoarse voice typically eliminates the need for testing and points toward a viral origin. The Centor criteria can help determine who needs group A &#x003b2;-hemolytic&#x000a0;<italic toggle="yes">Streptococcus&#x000a0;</italic>testing when the presentation is unclear.</p>
        <p>Though less common, additional causes of bacterial pharyngitis are group C and G streptococci, sexually transmitted infections like&#x000a0;<italic toggle="yes">Neisseria&#x000a0;gonorrhea&#x000a0;</italic>and&#x000a0;<italic toggle="yes">Treponema pallidum,&#x000a0;<italic toggle="yes">Corynebacterium diphtheriae</italic>&#x000a0;</italic>in places where vaccination rates are low, <italic toggle="yes">Mycoplasma pneumoniae,&#x000a0;</italic>and&#x000a0;<italic toggle="yes">Chlamydia pneumoniae</italic><italic toggle="yes">.&#x000a0;</italic>These alternatives<italic toggle="yes">&#x000a0;</italic>should be considered based on the patient's physical examination, sexual, travel, and vaccination history or when a patient fails to improve after treatment with standard therapy.</p>
        <p>This activity for healthcare professionals is designed to enhance the learner&#x02019;s competence when diagnosing and managing bacterial pharyngitis, leading to improved clinical decision-making, accurate identification of bacterial infections, and appropriate utilization of diagnostic tools, thereby reducing unnecessary testing and treatment.&#x000a0;Participants gain a deeper insight into the condition's&#x000a0;clinical manifestations, diagnostic strategies, and therapeutic interventions.&#x000a0;By navigating the intricacies of diagnosing bacterial pharyngitis, clinicians can optimize patient care, mitigate antibiotic overuse and resistance, and enhance healthcare outcomes. Greater proficiency increases the learner's ability to collaborate within an interprofessional team caring for patients with bacterial pharyngitis.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical features suggestive of bacterial pharyngitis.</p></list-item><list-item><p>Implement appropriate diagnostic tests for bacterial pharyngitis.&#x000a0;</p></list-item><list-item><p>Create an individualized, evidence-based treatment plan for a patient diagnosed with bacterial pharyngitis.</p></list-item><list-item><p>Collaborate with the healthcare team to develop and implement strategies for appropriate antibiotic stewardship in managing bacterial pharyngitis, ensuring optimal patient outcomes while minimizing antibiotic resistance and adverse effects.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27105&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27105">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27105.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pharyngitis, an inflammation of the pharynx resulting in a sore throat, is a common condition primarily attributed to noninfectious or viral causes. However, identifying and treating bacterial pharyngitis is pivotal in preventing potential long-term complications. With the etiology of sore throat varying across age groups, a strategic assessment becomes imperative to discern patients who require testing and treatment for bacterial causes,&#x000a0;are potentially at risk for sexually transmitted infections like HIV, or harbor life-threatening conditions inducing airway obstruction or death.&#x000a0;Distinguishing between viral and bacterial pharyngitis can be challenging as their symptoms may overlap.</p>
        <p>Group A &#x003b2;-hemolytic <italic toggle="yes">Streptococcus</italic> (GABS), or <italic toggle="yes">Streptococcus pyogenes</italic>, is the leading cause of bacterial pharyngitis, potentially leading to serious complications like retropharyngeal abscess, meningitis, rheumatic fever, glomerulonephritis, and toxic shock syndrome if untreated. Accurate identification of bacterial pharyngitis and determining when to investigate less common causes are crucial for preventing unnecessary testing, treatment, and complications from untreated infections.<xref ref-type="bibr" rid="article-27105.r1">[1]</xref>&#x000a0;</p>
        <p>While the goals of antibiotic therapy for bacterial pharyngitis are symptom alleviation, complication prevention, and interruption of transmission, reliance solely on physical examination for diagnosing GABS infection is inadequate. Instead, confirmatory tests such as rapid antigen detection testing (RADT), nucleic acid amplification testing (NAAT),&#x000a0;and throat culture become indispensable. Concurrent symptoms like rhinorrhea, cough, oral ulcers, viral exanthem, conjunctivitis,&#x000a0;and hoarseness typically favor a viral etiology, eliminating the need for testing.</p>
        <p>The Centor criteria offer valuable guidance in determining the necessity of GABS&#x000a0;testing in ambiguous presentations. Although less prevalent, sexually transmitted infections like&#x000a0;<italic toggle="yes">Neisseria gonorrhea</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Treponema pallidum</italic>,&#x000a0;<italic toggle="yes">Corynebacterium diphtheriae</italic>&#x000a0;in undervaccinated regions, and zoonotic agents like&#x000a0;<italic toggle="yes">Francisella</italic>&#x000a0;<italic toggle="yes">tularensis</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Yersinia pestis</italic>&#x000a0;pose alternative considerations based on clinical evaluation and patient history.</p>
      </sec>
      <sec id="article-27105.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Acute pharyngitis is quite common in children and adults. Common noninfectious causes are allergic rhinitis or sinusitis, gastroesophageal reflux disease, smoking or exposure to second-hand smoke, and exposure to dry air. In addition, Kawasaki disease, Beh&#x000e7;et syndrome, chemotherapy agents, and angiotensin-converting enzyme inhibitors also&#x000a0;produce symptoms of pharyngitis.<xref ref-type="bibr" rid="article-27105.r2">[2]</xref></p>
        <p>GABS are gram-positive cocci arranged in chains or pairs and are the most common bacterial etiology of pharyngitis, producing what is commonly referred to as "strep throat."<xref ref-type="bibr" rid="article-27105.r3">[3]</xref>&#x000a0;Transmitted via airborne transmission or ingestion, the only known reservoirs of GABS are human skin and mucous membranes. Infection generally peaks in winter and early spring and is most common in&#x000a0;school-age children. Additional causes of bacterial pharyngitis include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Group C and G <italic toggle="yes">Streptococcus</italic>: These organisms present identically to GABS,&#x000a0;most frequently affect college students and young adults, and are associated with community and foodborne outbreaks.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Neisseria&#x000a0;gonorrhea</italic>:<italic toggle="yes">&#x000a0;</italic>A&#x000a0;gram-negative coccus generally acquired by oral sexual exposure. Pharyngitis associated with&#x000a0;<italic toggle="yes">N gonorrhea</italic><italic toggle="yes">&#x000a0;</italic>occurs<italic toggle="yes">&#x000a0;</italic>most commonly in men who have sex with men.<xref ref-type="bibr" rid="article-27105.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Chlamydia trachomatis</italic>:&#x000a0;This&#x000a0;gram-negative rod does not typically cause pharyngitis, but the pharynx can be a reservoir for infection.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Treponema pallidum</italic>:<italic toggle="yes">&#x000a0;</italic>A&#x000a0;spirochete bacterium transmitted sexually.&#x000a0;Pharyngitis is a common presenting symptom in patients with secondary syphilis.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Arcanobacterium haemolyticum</italic><italic toggle="yes">&#x000a0;</italic>(formerly&#x000a0;<italic toggle="yes">Corynebacterium haemolyticum</italic>):&#x000a0;This uncommon cause of pharyngitis is an anaerobic gram-positive bacillus spreading through infected respiratory droplets,&#x000a0;especially&#x000a0;in adolescents and young adults.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Fusobacterium necrophorum</italic>:&#x000a0;A gram-negative rod that often colonizes the oropharynx and is likely a&#x000a0;secondary invader rather than a causative pathogen.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Mycoplasma pneumoniae&#x000a0;</italic>and&#x000a0;<italic toggle="yes">Chlamydia pneumoniae:</italic><italic toggle="yes">&#x000a0;</italic>Both spread via respiratory droplets.&#x000a0;<italic toggle="yes">M. pneumoniae&#x000a0;</italic>is a short rod with no cell wall and is not visible on gram stain<italic toggle="yes">. C pneumoniae</italic>&#x000a0;is a gram-negative bacteria. Pharyngitis is most common in children and young adults and often occurs with a lower respiratory tract infection.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Corynebacterium diphtheria</italic>:<italic toggle="yes">&#x000a0;</italic>A gram-positive&#x000a0;club-shaped bacillus transmitted via infected respiratory droplets. Diphtheria is rare in the United States and other places with high immunization rates.<xref ref-type="bibr" rid="article-27105.r5">[5]</xref><xref ref-type="bibr" rid="article-27105.r6">[6]</xref><xref ref-type="bibr" rid="article-27105.r7">[7]</xref></p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Francisella tularensis</italic>:<italic toggle="yes">&#x000a0;</italic>This organism is a gram-negative coccobacillus that causes pharyngeal tularemia. Infection occurs via the skin when handling infected animal tissue or inhaling contaminated dust or aerosols.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Yersinia pestis: </italic>This organism is a&#x000a0;gram-negative&#x000a0;coccobacillus,&#x000a0;transmitted by fleas, that causes the plague.&#x000a0;</p>
          </list-item>
        </list>
        <p>Pharyngitis has a broad differential, encompassing both infectious and noninfectious etiologies, thus requiring careful evaluation of symptoms and risk factors. Identifying the underlying cause is essential for appropriate management and prevention of complications.</p>
      </sec>
      <sec id="article-27105.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Pharyngitis is a widespread complaint in healthcare professionals' offices, emergency departments, and urgent care centers, accounting for approximately 12 million annual visits in the United States.<xref ref-type="bibr" rid="article-27105.r8">[8]</xref>&#x000a0;This figure represents 1% to 2% of all outpatient visits. Nearly 50% of these visits occur in children, with the remaining adult cases peaking by age 40.<xref ref-type="bibr" rid="article-27105.r9">[9]</xref><xref ref-type="bibr" rid="article-27105.r10">[10]</xref></p>
        <p>Viral causes account for 70% to 90% of acute cases, primarily driven by rhinovirus, the cause of the common cold. GABS infection constitutes&#x000a0;5% to 15% of cases of acute pharyngitis in developed countries and is more common in school-age children. Group C and G streptococci comprise 5% to 10%,&#x000a0;while&#x000a0;<italic toggle="yes">A haemolyticum </italic>accounts for&#x000a0;1% to 2.5% of cases.<xref ref-type="bibr" rid="article-27105.r11">[11]</xref><xref ref-type="bibr" rid="article-27105.r12">[12]</xref></p>
        <p>The exact prevalence of&#x000a0;<italic toggle="yes">M pneumoniae&#x000a0;</italic>and&#x000a0;<italic toggle="yes">C pneumoniae&#x000a0;</italic>is unknown. Unvaccinated populations or regions of the world where the disease remains endemic confine cases of diphtheria.&#x000a0;Most pharyngeal infections with&#x000a0;<italic toggle="yes">N gonorrhea&#x000a0;</italic>are asymptomatic. Studies reveal the prevalence of pharyngeal gonorrhea in men who have sex with men is approximately 15%.<xref ref-type="bibr" rid="article-27105.r13">[13]</xref>&#x000a0;Antibiotic prescriptions are given to 49% to 57% of children and 64% of adults with pharyngitis, often exceeding the prevalence of bacterial infection warranting treatment.<xref ref-type="bibr" rid="article-27105.r14">[14]</xref>&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-27105.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Bacteria invade the mucosal tissues of the pharynx directly. The remaining details of the pathogenesis of bacterial pharyngitis vary based on the underlying pathogen.</p>
        <p>
<bold>Group A&#x000a0;&#x003b2;-Hemolytic&#x000a0;<italic toggle="yes">Streptococcus</italic></bold>
</p>
        <p>GABS has a number&#x000a0;of virulence factors that subvert the host's natural immune response. Cell surface proteins, hemolytic toxins, pyrogenic exotoxins, and bacterial structural components all contribute to its virulence. M and M-like proteins help the organism evade phagocytosis and complement deposition.<xref ref-type="bibr" rid="article-27105.r15">[15]</xref>&#x000a0;Toxins like streptolysin O further exacerbate tissue damage by affecting platelets and endothelial cells, leading to ischemic injury.<xref ref-type="bibr" rid="article-27105.r16">[16]</xref>&#x000a0;Streptolysin S lyses red blood cells.&#x000a0;Hyaluronidase&#x000a0;aids in infection spread along fascial planes by breaking down hyaluronic acid in connective tissue.</p>
        <p>All GABS strains secrete streptokinase and have plasminogen binding sites on the surface. When plasminogen binds, streptokinase converts plasminogen to plasmin and interrupts the coagulation cascade, aiding the spread of infection to deep tissues.<xref ref-type="bibr" rid="article-27105.r17">[17]</xref> Streptokinase is also involved in the development of poststreptococcal glomerulonephritis.&#x000a0;Some strains secrete S<italic toggle="yes">treptococcus pyogenes</italic>&#x000a0;nicotinamide-adenine dinucleotidase, which is translocated into the host cells to deplete nicotinamide adenine dinucleotide stores. See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22287">Poststreptococcal Glomerulonephritis</ext-link>," for additional information regarding the pathophysiology of poststreptococcal glomerulonephritis.&#x000a0;</p>
        <p>Streptococcal pyrogenic exotoxins elicit lymphocyte blastogenesis, exacerbate endotoxin-induced shock, cause&#x000a0;fever, dampen antibody synthesis, and function as superantigens. The toxins contribute to fever and shock by reducing the threshold for endotoxin effects, prompting human mononuclear cells to produce tumor necrosis factor-&#x003b1;, interleukin-1, and interleukin-6.</p>
        <p>Streptococcal pyrogenic exotoxins&#x000a0;also contribute to scarlet fever and toxic shock syndrome by acting as superantigens and stimulating T-cell responses.<xref ref-type="bibr" rid="article-27105.r18">[18]</xref>&#x000a0;Binding occurs at both the class II major histocompatibility complex of antigen-presenting cells and the V &#x003b2; region of the T-cell receptor, prompting T cells to synthesize interleukin-1, tumor necrosis factor-&#x003b1;, tumor necrosis factor-&#x003b2;, interleukin-6, and interferon-&#x003b3;.&#x000a0;See StatPearls' companion references, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/30298">Toxic Shock Syndrome</ext-link>"&#x000a0;and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/28741">Scarlet Fever</ext-link>,"&#x000a0;for more detailed information regarding the pathogenesis of these complications related to GABS infection.&#x000a0;</p>
        <p>
<bold>Other Bacterial Causes</bold>
</p>
        <p>Less common bacterial agents that cause acute pharyngitis include&#x000a0;<italic toggle="yes">C diphtheria,&#x000a0;<italic toggle="yes">N gonorrhea,&#x000a0;<italic toggle="yes">T pallidum, and&#x000a0;<italic toggle="yes">M pneumoniae.&#x000a0;</italic></italic></italic></italic>Each of these pathogens presents distinct pathophysiological mechanisms, influencing both diagnosis and treatment approaches.</p>
        <p>
<bold>
<italic toggle="yes">Corynebacterium diphtheria</italic>
</bold>
</p>
        <p>Diphtheria symptoms result from local respiratory tract inflammation and the effects of exotoxin both locally and systemically. The toxin binds to cell membrane receptors and disrupts protein synthesis by inactivating elongation factor 2, leading to cell death.</p>
        <p>
<bold>
<italic toggle="yes">Neisseria&#x000a0;gonorrhea</italic>
</bold>
</p>
        <p><italic toggle="yes">N gonorrhea</italic> attaches to the host urethral, cervical, or other epithelial cells via type IV pili and other surface proteins. The pili and surface proteins undergo antigenic variation and various other complex processes to avoid detection by the host immune system.<xref ref-type="bibr" rid="article-27105.r19">[19]</xref>&#x000a0;Once bound to the host cells,&#x000a0;the organism becomes internalized, multiplies, and divides&#x000a0;intracellularly, protecting itself from the immune system and the local environment. Gonococcal infection dampens the host's immune response, preventing the formation of protective immunity against future infections.</p>
        <p>
<bold>
<italic toggle="yes">Treponema pallidum</italic>
</bold>
</p>
        <p><italic toggle="yes">T pallidum&#x000a0;</italic>causes infection wherever inoculation occurs. Primary syphilis presents as a&#x000a0;painless chancre at the site of inoculation after an incubation period of 3 to 6 weeks. The chancre initially contains polymorphonuclear leukocytes, which are quickly replaced by T lymphocytes. Concurrently, the host develops a&#x000a0;humoral immune response, leading to the development of antibodies detected early in the disease course. While the immune response eliminates the&#x000a0;chancre, it does not control the dissemination of the spirochete throughout the body in untreated patients.&#x000a0;</p>
        <p>
<bold>
<italic toggle="yes">Mycoplasma pneumoniae</italic>
</bold>
</p>
        <p>The underlying pathophysiology of&#x000a0;<italic toggle="yes">M. pneumoniae </italic>pharyngitis&#x000a0;is not fully understood.&#x000a0;<italic toggle="yes">M pneumoniae&#x000a0;</italic>has a selective affinity for the respiratory epithelium<italic toggle="yes">.&#x000a0;</italic>Once bound,<italic toggle="yes">&#x000a0;M pneumoniae&#x000a0;</italic>secretes hydrogen peroxide and superoxide, which damages the epithelial cells and their cilia. Some remain on the cell surface, and some can invade the host cells, protected from the host's immune response.<xref ref-type="bibr" rid="article-27105.r20">[20]</xref>&#x000a0;Extrapulmonary manifestations like&#x000a0;hemolysis and encephalitis may be due to antibodies produced against the glycolipid antigens of&#x000a0;<italic toggle="yes">M pneumoniae</italic>&#x000a0;that cross-react with human red cells and brain cells&#x000a0;and act as autoantibodies.&#x000a0;See StatPearls' companion references, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/27269">Plague</ext-link>" and "&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/30676">Tularemia</ext-link>,"&#x000a0;for specific details regarding the pathophysiology of&#x000a0;<italic toggle="yes">Y.</italic><italic toggle="yes">&#x000a0;pestis-&#x000a0;</italic>and<italic toggle="yes">&#x000a0;F tularensis-</italic>induced disease.</p>
        <p>Recognizing the diverse bacterial causes of acute pharyngitis is essential for effective treatment. Each pathogen's unique infectious mechanisms require tailored approaches to ensure proper management and reduce the risk of complications.</p>
      </sec>
      <sec id="article-27105.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The initial history and physical examination help clinicians exclude potentially life-threatening conditions and identify treatable causes of pharyngitis.&#x000a0;Key historical features for diagnosing pharyngitis include the rapidity of onset and the presence or absence of symptoms such as respiratory distress, fever, and fatigue. Additional relevant factors are recent exposure to sick contacts, history of immunocompromised conditions, vaccination and travel history, sexual history, and previous episodes of pharyngitis. Fever suggests an infectious cause, and respiratory distress indicates an obstructive process like&#x000a0;epiglottitis or retropharyngeal or peritonsillar abscess. Pharyngitis, fever, and severe fatigue may indicate infectious mononucleosis.&#x000a0;</p>
        <p>
<bold>Group A &#x003b2;-hemolytic&#x000a0;<italic toggle="yes">Streptococcus</italic>&#x000a0;</bold>
</p>
        <p>Pharyngitis caused by GABS in children 3 years or older typically has an abrupt onset accompanied by fever, headache, and abdominal pain, occasionally associated with nausea and vomiting. Children younger than 3 often do not have a clearly defined case of pharyngitis. These patients may also have accompanying nasal congestion and discharge.&#x000a0;Infants&#x000a0;younger than 1 year often present with fussiness, decreased appetite, and low-grade fever. These patients often have a family member or daycare contact with GABS. Adults tend to present with an acute-onset sore throat and fever.</p>
        <p>Classic physical examination findings are exudative&#x000a0;tonsillopharyngitis, enlarged tender anterior cervical lymph nodes, petechiae on the palate, and a strawberry tongue.&#x000a0;Additionally, some patients may have a fine papular rash that begins in the groin and axilla, followed by spread to the trunk and extremities. The affected areas eventually undergo desquamation.<xref ref-type="bibr" rid="article-27105.r21">[21]</xref>&#x000a0;</p>
        <p>
<bold>
<italic toggle="yes">Treponema pallidum</italic>
</bold>
</p>
        <p>Primary syphilis presents as a chancre, or painless ulceration, at the site of inoculation. Approximately 25% of patients develop secondary syphilis, a systemic illness marked by rash, fever, headache, myalgias, pharyngitis, and gastrointestinal symptoms. Most patients also have posterior cervical, axillary, inguinal, and femoral lymphadenopathy. Epitrochlear nodes highly suggest the diagnosis. The rash, the most characteristic feature, is macular or papular and symmetric, involving the entire trunk and extremities, including the palms and soles.<xref ref-type="bibr" rid="article-27105.r22">[22]</xref>&#x000a0;</p>
        <p>
<bold><italic toggle="yes">Mycoplasma pneumoniae</italic>&#x000a0;</bold>
</p>
        <p><italic toggle="yes">M pneumoniae</italic>&#x000a0;presents in an atypical fashion for bacterial pharyngitis. Patients may experience symptoms similar to a viral upper respiratory infection, like a nonexudative sore throat, coryza, headache, ear pain, and a prolonged cough.<xref ref-type="bibr" rid="article-27105.r23">[23]</xref>&#x000a0;Physical examination findings may include pharyngeal edema, wheezing, otitis media, and other symptoms consistent with an upper respiratory infection. Others may have pharyngitis associated with pneumonia. Pneumonia associated with&#x000a0;<italic toggle="yes">M. pneumoniae&#x000a0;</italic>typically has a gradual onset,&#x000a0;and the lung examination may be normal initially, with rales and wheezing developing later in the course.&#x000a0;</p>
        <p>
<bold><italic toggle="yes">Chlamydia Pneumoniae</italic>&#x000a0;</bold>
</p>
        <p><italic toggle="yes">C pneumoniae</italic>&#x000a0;can cause various infections, including&#x000a0;pharyngitis, laryngitis, otitis media, and bronchitis.&#x000a0;In conjunction with pneumonia, upper respiratory symptoms like&#x000a0;pharyngitis, laryngitis, or sinusitis may signify&#x000a0;<italic toggle="yes">a C pneumoniae</italic> infection.</p>
        <p>
<bold>
<italic toggle="yes">Corynebacterium diphtheria</italic>
</bold>
</p>
        <p>Like GABS, diphtheria presents with a sore throat, malaise, cervical lymphadenopathy, and fever. Though the onset of diphtheria is gradual, additional symptoms may be hoarseness, cough, and purulent nasal discharge. The formation of a pseudomembrane can progress, causing respiratory stridor and death. Initially, patients exhibit mild pharyngeal edema and erythema followed by isolated gray and white exudate spots&#x02014;approximately 33% progress to form a coalescing, tightly adherent pseudomembrane that bleeds with scraping.</p>
        <p>
<bold>
<italic toggle="yes">Francisella tularensis</italic>
</bold>
</p>
        <p>Pharyngeal tularemia presents with&#x000a0;fever, severe&#x000a0;sore throat, and swelling in the neck. Physical examination findings are exudative&#x000a0;pharyngitis&#x000a0;and tonsillitis with cervical lymph node enlargement. Distinguishing features are pharyngeal or tonsillar ulcers and a pharyngeal membrane mimicking diphtheria.<xref ref-type="bibr" rid="article-27105.r24">[24]</xref></p>
        <p>
<bold>
<italic toggle="yes">Yersinia pestis</italic>
</bold>
</p>
        <p><italic toggle="yes">Y</italic><bold><italic toggle="yes">&#x000a0;</italic></bold><italic toggle="yes">pestis&#x000a0;</italic>most commonly presents as acute febrile lymphadenitis or bubonic plague. Rarely, if the patient has ingested&#x000a0;<italic toggle="yes">Y pestis</italic>,<italic toggle="yes">&#x000a0;</italic>the plague can manifest as pharyngitis and tonsillitis associated with anterior cervical lymphadenitis.<xref ref-type="bibr" rid="article-27105.r25">[25]</xref></p>
      </sec>
      <sec id="article-27105.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>General Evaluation</bold>
</p>
        <p>Most of the evaluation for acute pharyngitis encompasses a comprehensive history and physical examination with testing in select patients. Clinicians begin with assessing vital signs for fever and evidence of clinical instability. A thorough&#x000a0;otolaryngological examination evaluates the ears, conjunctiva, and nares for associated findings or referred symptoms mimicking pharyngitis.</p>
        <p>Evaluation of the oropharynx and neck should assess for tonsilar and pharyngeal erythema, swelling, and exudates along with lymphadenopathy. Exudates or a pseudomembrane favors a bacterial etiology, as do swollen and tender anterior cervical lymph nodes. Conjunctivitis, swelling of the nasal turbinates, oral ulcers, and postnasal drip favor nonbacterial etiologies.<xref ref-type="bibr" rid="article-27105.r26">[26]</xref>&#x000a0;A skin examination revealing a red rash that feels like sandpaper indicates scarlet fever and GABS infection. Other rashes may suggest viral respiratory infections or syphilis.</p>
        <p>When evaluating patients with acute pharyngitis, the initial step is to exclude life-threatening conditions like diphtheria or an abscess in the peritonsillar, submandibular, or retropharyngeal spaces requiring immediate intervention. These patients will be toxic-appearing, with fever and rigors. Additional findings may include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>A muffled voice, often referred to as a "hot potato" voice</p>
          </list-item>
          <list-item>
            <p>Hoarseness</p>
          </list-item>
          <list-item>
            <p>Drooling</p>
          </list-item>
          <list-item>
            <p>Stridor</p>
          </list-item>
          <list-item>
            <p>Sitting in a "tripod" position</p>
          </list-item>
          <list-item>
            <p>Tachypnea, dyspnea, or retractions</p>
          </list-item>
          <list-item>
            <p>Bulging of pharyngeal wall, soft palate, or floor of the oropharynx</p>
          </list-item>
          <list-item>
            <p>Crepitus</p>
          </list-item>
          <list-item>
            <p>Trismus</p>
          </list-item>
          <list-item>
            <p>Stiff neck</p>
          </list-item>
        </list>
        <p>Clinicians establish the diagnosis of viral pharyngitis based on the presence of cough, nasal congestion, conjunctivitis, coryza, oral ulcers, and viral exanthems. The associated complications and treatments differ for respiratory viral and bacterial pharyngitis. Thus, distinguishing between these conditions is essential.</p>
        <p>
<bold>Group A &#x003b2;-hemolytic&#x000a0;<italic toggle="yes">Streptococcus</italic>&#x000a0;Testing</bold>
</p>
        <p>Evaluating acute pharyngitis involves identifying specific symptoms and risk factors to determine the appropriate diagnostic tests. Testing decisions are guided by clinical criteria&#x000a0;that help assess the likelihood of GABS infection and other causes.</p>
        <p>
<bold>Who to test</bold>
</p>
        <p>Adults with symptoms consistent with GABS pharyngitis like acute symptom onset, fever, tonsillopharyngeal or uvular edema, anterior cervical lymphadenitis, patchy tonsillar exudates, scarlatiniform skin rash, strawberry tongue, or a known exposure to GABS without typical respiratory virus symptoms should undergo microbiological testing for GABS. The Centor criteria help clinicians determine which adults to test if the decision is unclear. The Centor criteria include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tonsillar exudates</p>
          </list-item>
          <list-item>
            <p>Tender anterior cervical lymphadenopathy</p>
          </list-item>
          <list-item>
            <p>Fever</p>
          </list-item>
          <list-item>
            <p>Absence of cough</p>
          </list-item>
        </list>
        <p>Patients receive 1 point for each criterion they meet.&#x000a0;Individuals who meet 3 or more criteria warrant testing for GABS.<xref ref-type="bibr" rid="article-27105.r27">[27]</xref><xref ref-type="bibr" rid="article-27105.r28">[28]</xref>&#x000a0;Patients with&#x000a0;fewer&#x000a0;than 3 of these manifestations are less likely to have GABS pharyngitis,&#x000a0;making further testing unnecessary. Clinicians should remember that the Centor criteria have low sensitivity, and they should not bypass their clinical impressions to determine the need for antibiotic therapy. The McIsaac criteria&#x000a0;derive from the original Centor criteria&#x000a0;but account for age differences by adding a point for patients aged 3&#x000a0;to 14 and subtracting a point for patients aged 45 or older.<xref ref-type="bibr" rid="article-27105.r29">[29]</xref></p>
        <p>The FeverPAIN criteria include fever, tonsillar exudates, severe inflammation, onset within 3 days, and the absence of cough or coryza. Again, patients meeting fewer criteria (0 to 1) are unlikely to have strep infections, while those meeting more criteria (4 or more) are more likely to be infected.<xref ref-type="bibr" rid="article-27105.r30">[30]</xref>&#x000a0;Clinical scoring systems for GABS&#x000a0;are insufficiently sensitive or specific to eliminate the need for microbiologic testing in children and adolescents with suspected GABS.<xref ref-type="bibr" rid="article-27105.r31">[31]</xref>&#x000a0;The following list describes the parameters for testing in children and adolescents:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Children 3 years or older and adolescents with pharyngeal erythema, edema, and exudates or a scarlatiniform rash&#x000a0;on physical examination</p>
          </list-item>
          <list-item>
            <p>Children younger than age 3 with prolonged nasal discharge, tender anterior cervical adenopathy, and a low-grade fever of 101&#x000a0;&#x000b0;F (38.3 &#x000b0;C) or less, especially if they have a known GABS exposure</p>
          </list-item>
          <list-item>
            <p>Children with suspected acute rheumatic fever or poststreptococcal glomerulonephritis</p>
          </list-item>
          <list-item>
            <p>Any child with a history of acute rheumatic fever and a household member with a GABS infection</p>
          </list-item>
        </list>
        <p>Patients who warrant testing for GABS can undergo either a sensitive RADT or a NAAT.&#x000a0;Clinicians should collect specimens before beginning antimicrobial treatment and vigorously swab both tonsils or tonsillar fossae in patients without tonsils and the posterior pharynx. Accurate results are highly dependent on the collection of an adequate inoculum. Adults and older adolescents have a lower incidence of GABS pharyngitis than children and younger adolescents and an extremely low risk of developing acute rheumatic fever. Consequently, a follow-up throat culture for confirmation is unnecessary if either test&#x000a0;returns a negative result. A confirmatory throat culture is necessary in children if the result of the GABS rapid test is negative.<xref ref-type="bibr" rid="article-27105.r32">[32]</xref>&#x000a0;</p>
        <p>Given NAAT's high sensitivity and specificity, clinicians can also use it for confirmation. RADTs have a sensitivity of 77% to 92% and a specificity of 88% to 99%.&#x000a0;However, solely using this test results in some false negative results unless clinicians follow with a confirmatory throat culture.<xref ref-type="bibr" rid="article-27105.r33">[33]</xref> For this reason, adults who are at higher risk for severe infection or complications from GABS pharyngitis, closely interact with others at risk for complications, live in college dorms where acute rheumatic fever is endemic, or potentially have GABS despite a negative RADT result should undergo a throat culture or NAAT testing. Clinicians do not typically treat empirically while awaiting throat culture results.</p>
        <p>
<bold>Testing for other bacterial causes</bold>
</p>
        <p>Part of evaluating acute pharyngitis includes gathering historical information about sexual activity, potential blood-borne pathogen exposure, and recent intravenous drug use to assess the risk of HIV or other sexually transmitted infections. HIV and <italic toggle="yes">N gonorrhea</italic> are the 2 most&#x000a0;frequent causes of sexually transmitted pharyngitis.</p>
        <p>Symptoms of acute HIV infection include fever, pharyngitis, adenopathy in the cervical, axillary, and inguinal regions, headaches, myalgias, rash, and mucocutaneous ulcerations. Testing for suspected early HIV infection requires both a combination antigen/antibody test and an HIV viral load assessment. Clinicians should repeat testing in 1 to 2 weeks if initial tests are negative, but suspicion remains high. A negative antigen/antibody test with a positive HIV viral load suggests acute infection. A viral load of less than 100 copies/mL may indicate a false positive, necessitating repeat testing. A second positive viral load confirms infection.</p>
        <p>Pharyngeal gonorrhea and chlamydia are often asymptomatic.&#x000a0;Consequently, NAAT swab testing is recommended for patients at increased risk or when acute pharyngitis does not respond to standard treatment.<xref ref-type="bibr" rid="article-27105.r34">[34]</xref> Culture serves as an alternative. Increased risk for syphilis infection is seen in men who have sex with men and patients with HIV. Syphilis screening traditionally starts with a nontreponemal test, such as the rapid plasma reagin (RPR) test, with confirmation using a treponemal test, like the fluorescent treponemal antibody absorption (FTA-ABS). More recent protocols reverse this order, beginning with a treponemal test, followed by a nontreponemal test for confirmation. This reverse method enhances the detection of early syphilis, cases previously treated, and late or late latent syphilis, where the nontreponemal test may become nonreactive over time.</p>
        <p>Patients who do not respond to appropriate therapy may require a routine aerobic pharyngeal culture to&#x000a0;test for group C or G streptococci, <italic toggle="yes">A haemolyticum</italic>, and <italic toggle="yes">F necrophorum</italic>. For suspected diphtheria, a culture should be obtained from both the membrane and beneath it. A presumptive diagnosis is supported by the appearance of gram-positive rods in a "Chinese character" distribution on gram stain, black colonies with halos on Tinsdale media, and metachromatic granules on L&#x000f6;ffler media. Biochemical testing confirms the diagnosis, and additional testing for toxin production is necessary to differentiate toxigenic from nontoxigenic strains of <italic toggle="yes">C. diphtheriae</italic>. In cases of suspected tularemia, serology should be performed and repeated in 2 to 4 weeks.</p>
        <p>
<bold>Imaging</bold>
</p>
        <p>Imaging should be considered when clinical instability, difficulty swallowing, or restricted neck movement is observed. For epiglottitis, a plain radiograph typically shows an abnormal epiglottis.&#x000a0;A retropharyngeal abscess may show some changes on plain radiographs, but computed tomography or magnetic resonance imaging is preferred for a more detailed evaluation. Radiographic findings often include increased thickness of the prevertebral soft tissue, swelling, and gas collections in the retropharyngeal space, leading to anterior displacement of the larynx and trachea.<xref ref-type="bibr" rid="article-27105.r35">[35]</xref>&#x000a0;Typically, the pharynx or upper airway is displaced anteriorly by more than half the width of the 4th cervical vertebral body.</p>
      </sec>
      <sec id="article-27105.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The goals of treating bacterial pharyngitis are to relieve symptoms and prevent complications. Healthcare professionals do not treat the infection empirically&#x000a0;but&#x000a0;use the appropriate antibiotics after confirming the infection. Patients should also get adequate rest and fluids and eat a soft diet, taking&#x000a0;nonsteroidal anti-inflammatory drugs (NSAIDs) for fever and pain relief. Studies reveal that NSAIDs are more effective than acetaminophen for symptom control.<xref ref-type="bibr" rid="article-27105.r36">[36]</xref></p>
        <p>
<bold>Group A &#x003b2;-hemolytic&#x000a0;<italic toggle="yes">Streptococcus</italic></bold>
</p>
        <p>The first-line treatment for children and adults with GABS is oral penicillin V. Amoxicillin is an acceptable alternative, and children may prefer it due to its taste. Penicillin is the only studied antibiotic shown to reduce the rates of acute rheumatic fever, and no documented cases of penicillin resistance exist.&#x000a0;Patients with a history of acute rheumatic fever who are not on antibiotic prophylaxis receive oral penicillin V, amoxicillin, or a single dose of intramuscular penicillin G benzathine.<xref ref-type="bibr" rid="article-27105.r37">[37]</xref>&#x000a0;The recommended doses are stated below.</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults:&#x000a0;Oral penicillin V 500 mg 2 to 3 times/d for 10 days, oral amoxicillin 500 mg twice/d for 10 days, or intramuscular (IM) penicillin G benzathine 1.2 million U once</p>
          </list-item>
          <list-item>
            <p>Children:
<list list-type="bullet"><list-item><p>Oral penicillin V 250 mg 2 to 3 times/d for 10 days&#x000a0;in patients weighing 27 kg or less</p></list-item><list-item><p>Oral penicillin V 500 mg 2 to 3 times/d for 10 days&#x000a0;in patients weighing more than 27 kg</p></list-item><list-item><p>Oral amoxicillin&#x000a0;50 mg/kg/d to a maximum of 1000 mg/d for 10 days given daily or in 2 divided doses</p></list-item><list-item><p>Penicillin G benzathine 600,000 units IM as a single&#x000a0;dose&#x000a0;in patients weighing 27 kg or less</p></list-item><list-item><p>Penicillin G benzathine 1.2 million units IM as a single dose&#x000a0;in patients weighing more than 27 kg</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Despite symptom improvement within a few days, eradication from the oropharynx is more effective with a 10-day treatment compared to 5 to 7 days of use. Alternatives for patients who are allergic or unable to tolerate penicillin include cephalosporins, clindamycin, and macrolides. Cephalosporins are suitable&#x000a0;in&#x000a0;cases of&#x000a0;mild penicillin allergy&#x000a0;not mediated by immunoglobulin E or penicillin unavailability. Using a narrow-spectrum cephalosporin, such as cephalexin, helps avoid resistance. Azithromycin or clarithromycin is recommended in cases of severe penicillin allergy. The recommended doses are stated below.</p>
        <list list-type="bullet">
          <list-item>
            <p>Adults:
<list list-type="bullet"><list-item><p>Oral azithromycin 500 mg/d for 3 days&#x000a0;</p></list-item><list-item><p>Oral clarithromycin 250 mg twice/d for 10 days&#x000a0;</p></list-item><list-item><p>Oral clindamycin 300 mg 3 times/d for 10 days</p></list-item><list-item><p>Oral cephalexin 500 mg twice/d for 10 days</p></list-item><list-item><p>Oral cefuroxime 250 mg twice/d for 10 days</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Children:
<list list-type="bullet"><list-item><p>Oral azithromycin 12 mg/kg/d maximum 500 mg/d for 3 days&#x000a0;</p></list-item><list-item><p>Oral clarithromycin 7.5 mg/kg/dose twice/d to a maximum of 250 mg per dose for 10 days</p></list-item><list-item><p>Oral clindamycin&#x000a0;7 mg/kg/dose 3 times/d to a maximum of 300 mg per dose for 10 days</p></list-item><list-item><p>Oral cephalexin&#x000a0;40 mg/kg/d divided twice daily for 10 days to a maximum of 500 mg/dose</p></list-item><list-item><p>Oral cefuroxime&#x000a0;10 mg/kg/dose twice/d to a maximum of 250 mg/dose for 10 days&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>The macrolides azithromycin and clarithromycin have an increasing resistance rate and are associated with gastrointestinal symptoms and prolongation of the corrected QT interval, which&#x000a0;may lead to torsades de pointes. Clindamycin also exhibits increasing resistance rates, and patients taking this medication often experience gastrointestinal adverse effects. The cephalosporins encompass a broader spectrum than penicillin and pose a more significant potential to create antibiotic resistance. Patients can return to work, school, or daycare 24 hours after starting antibiotics.</p>
        <p>
<bold>Other Bacterial Infections</bold>
</p>
        <p>Clinicians should treat pharyngeal gonorrhea or chlamydia infections the same way as a genital infection,&#x000a0;with consideration for&#x000a0;gonorrhea and chlamydia cotreatment. Gonorrhea therapeutic guidelines from the United States Centers for Disease Control and Prevention (CDC) include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>For individuals who weigh less than 150 kg, ceftriaxone 500 mg IM in a single&#x000a0;dose</p>
          </list-item>
          <list-item>
            <p>For individuals weighing 150 kg or more, ceftriaxone 1 g IM in a single dose&#x000a0;<xref ref-type="bibr" rid="article-27105.r38">[38]</xref></p>
          </list-item>
        </list>
        <p>If concurrent NAAT testing for chlamydia is not performed, nonpregnant individuals should be treated with doxycycline 100 mg twice daily for 7 days. Azithromycin 1 g orally as a single dose&#x000a0;or oral levofloxacin 500 mg/d&#x000a0;may serve as an alternative to doxycycline for the treatment of chlamydia.&#x000a0;&#x000a0;</p>
        <p>Clinicians should report documented cases of diphtheria to the CDC. Treatment involves airway protection and management with a low threshold for intubation by a clinician experienced in obtaining and maintaining a challenging airway. Erythromycin or penicillin is the first-line antibiotic treatment. Antitoxin, obtained from the CDC, can reduce mortality from 7% to less than 1%.<xref ref-type="bibr" rid="article-27105.r39">[39]</xref>&#x000a0;Patients should be placed on respiratory droplet and contact isolation until therapy is complete, and 2 consecutive cultures taken from the nose and throat 24 hours apart both yield negative results.<xref ref-type="bibr" rid="article-27105.r40">[40]</xref></p>
        <p>Local infectious complications of acute pharyngitis, such as a peritonsillar abscess, should be managed in a hospital setting, where clinicians can intervene with appropriate surgical and specialist support.&#x000a0;Patients with a peritonsillar abscess warrant antimicrobials, surgical drainage, and supportive care. More studies are needed before clinicians determine glucocorticoids' benefits in managing a peritonsillar abscess.&#x000a0;Individuals with cellulitis can receive antimicrobials and supportive care alone.&#x000a0;Patients with necrotizing fasciitis require immediate surgical exploration, debridement, and antimicrobials. In addition,&#x000a0;individuals who develop toxic shock syndrome, marked by shock and multiorgan failure, should receive intravenous immune globulin along with surgical debridement and appropriate antimicrobial therapy.<xref ref-type="bibr" rid="article-27105.r41">[41]</xref><xref ref-type="bibr" rid="article-27105.r42">[42]</xref></p>
      </sec>
      <sec id="article-27105.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>As noted,&#x000a0;most&#x000a0;cases of acute pharyngitis are either noninfectious or viral. When evaluating the possibility of bacterial pharyngitis, healthcare professionals should also consider the following diagnoses:</p>
        <list list-type="bullet">
          <list-item>
            <p>Seasonal allergies</p>
          </list-item>
          <list-item>
            <p>Irritant pharyngitis due to gastroesophageal reflux disease or smoking</p>
          </list-item>
          <list-item>
            <p>Traumatic pharyngitis due to excessive shouting, snoring, or recent endotracheal intubation</p>
          </list-item>
          <list-item>
            <p>Aphthous ulcers</p>
          </list-item>
          <list-item>
            <p>Viral pharyngitis due to common viral respiratory pathogens like adenovirus,&#x000a0;rhinovirus, or coronavirus</p>
          </list-item>
          <list-item>
            <p>Viral pharyngitis due to more serious pathogens like infectious mononucleosis or HIV</p>
          </list-item>
          <list-item>
            <p>Fungal infections such as esophageal candidiasis</p>
          </list-item>
          <list-item>
            <p>Lymphangitis</p>
          </list-item>
          <list-item>
            <p>Peritonsillar or retropharyngeal abscess</p>
          </list-item>
          <list-item>
            <p>Beh&#x000e7;et syndrome</p>
          </list-item>
          <list-item>
            <p>Stevens-Johnson syndrome</p>
          </list-item>
          <list-item>
            <p>Kawasaki disease</p>
          </list-item>
          <list-item>
            <p>Foreign bodies lodged in the mucosal folds of the tonsils or pharynx</p>
          </list-item>
          <list-item>
            <p>Referred pain from otitis media, dental abscess, and cervical adenitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Lemierre syndrome</p>
          </list-item>
          <list-item>
            <p>Herpetic stomatitis</p>
          </list-item>
          <list-item>
            <p>Periodic fever with aphthous stomatitis, pharyngitis, and adenitis (PFAPA syndrome)</p>
          </list-item>
          <list-item>
            <p>Chemical exposure</p>
          </list-item>
        </list>
        <p>Careful clinical evaluation and diagnostic testing can guide treatment and improve outcomes.</p>
      </sec>
      <sec id="article-27105.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Most cases of acute bacterial pharyngitis resolve spontaneously within 3 to 5 days without treatment. The exception is untreated pharyngeal gonorrhea, which takes approximately 16 weeks to resolve without treatment.<xref ref-type="bibr" rid="article-27105.r43">[43]</xref> Successful treatment of confirmed GABS pharyngitis with the appropriate antibiotics generally leads to a favorable prognosis, with rare instances of associated complications.<xref ref-type="bibr" rid="article-27105.r44">[44]</xref></p>
        <p>Some patients may experience recurrent infections within a month postantibiotic treatment, often due to nonadherence to treatment or repeated exposure. In such cases, alternative antibiotics, often with broader coverage, such as amoxicillin-clavulanic acid, clindamycin, or intramuscular penicillin G,&#x000a0;may be prescribed. Escalation to a 3rd-generation cephalosporin may be necessary if initial treatment involves a 1st-generation cephalosporin.&#x000a0;Emphasizing the importance of adherence to treatment and minimizing risks is crucial in managing recurrent infections.</p>
        <p>Sexually transmitted pharyngeal infections are easily treated and most commonly asymptomatic.&#x000a0;The rare infections of diphtheria, tularemia, and plague are treatable&#x000a0;when basic medical resources are available.&#x000a0;However, these infections may&#x000a0;have a poor prognosis since most cases develop in highly underresourced settings.<xref ref-type="bibr" rid="article-27105.r45">[45]</xref>&#x000a0;Diphtheria can have mortality rates in endemic regions, ranging from 3% to 20%, often due to resultant myocarditis or severely inadequate access to care.<xref ref-type="bibr" rid="article-27105.r46">[46]</xref>&#x000a0;Similarly, the mortality associated with <italic toggle="yes">Y. pestis</italic> ranges from less than 15% when treated to 60% to 100% when left untreated.<xref ref-type="bibr" rid="article-27105.r47">[47]</xref></p>
      </sec>
      <sec id="article-27105.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of bacterial pharyngitis generally include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Peritonsillar abscess</p>
          </list-item>
          <list-item>
            <p>Sinusitis</p>
          </list-item>
          <list-item>
            <p>Necrotizing fasciitis</p>
          </list-item>
          <list-item>
            <p>Submandibular abscesss</p>
          </list-item>
          <list-item>
            <p>Retropharyngeal abscess</p>
          </list-item>
          <list-item>
            <p>Parapharyngeal space infection</p>
          </list-item>
          <list-item>
            <p>Suppurative jugular thrombophlebitis or Lemiere syndrome due to&#x000a0;bacterial invasion and clot formation of the jugular vein</p>
          </list-item>
          <list-item>
            <p>Epiglottitis</p>
          </list-item>
          <list-item>
            <p>Meningitis</p>
          </list-item>
          <list-item>
            <p>Mastoiditis</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Pyomyositis</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Clostridioides</italic>&#x000a0;<italic toggle="yes">difficile</italic>&#x000a0;colitis&#x000a0;<xref ref-type="bibr" rid="article-27105.r48">[48]</xref><xref ref-type="bibr" rid="article-27105.r49">[49]</xref></p>
          </list-item>
        </list>
        <p>Physical examination findings of systemic toxicity, midline or unilateral swelling, or bulging of the posterior pharyngeal wall associated with sore throat, difficulty swallowing, and difficulty breathing may signify a retropharyngeal abscess. Trismus, induration, swelling below the mandibular angle, medial pharyngeal wall bulging, and systemic toxicity indicate a parapharyngeal space infection.&#x000a0;Patients may also experience facial and&#x000a0;cervical swelling and erythema, parotid gland&#x000a0;swelling and displacement, and purulent oral discharge since dental abscesses are the most common underlying cause. A peritonsillar abscess manifests as a high fever, odynophagia, unilateral sore throat, and otalgia. Classic signs include a muffled voice, trismus, unilateral deviation of the uvula toward the unaffected side, and soft palate fullness or edema.</p>
        <p>Patients with necrotizing fasciitis typically present with pain disproportionate to the examination findings, poorly defined erythema, edema extending beyond the area of erythema, fever, and the presence of skin bullae, necrosis, or ecchymosis. A characteristic finding is a diminished sensation of pain in the affected area.&#x000a0;</p>
        <p>As noted above, GABS pharyngitis can lead to suppurative complications, which encompass the extension of infection beyond the oropharynx, as well as nonsuppurative complications. Nonsuppurative complications are&#x000a0;immune phenomena and include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute rheumatic fever</p>
          </list-item>
          <list-item>
            <p>Poststreptococcal reactive arthritis</p>
          </list-item>
          <list-item>
            <p>Scarlet fever</p>
          </list-item>
          <list-item>
            <p>Acute glomerulonephritis</p>
          </list-item>
          <list-item>
            <p>Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci (PANDAS)</p>
          </list-item>
          <list-item>
            <p>Toxic shock syndrome</p>
          </list-item>
        </list>
        <p>The onset of acute rheumatic fever occurs 2 to 4 weeks following GABS infection, and patients may experience arthritis, carditis, chorea, subcutaneous nodules, and erythema marginatum. Most patients present with&#x000a0;an acute febrile illness with joint manifestations and, often, carditis. The diagnosis is clinical, based on the presence of major and minor criteria. See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/155742">Acute Rheumatic Fever</ext-link>," for additional information. The most common long-term outcome is rheumatic heart disease, occurring 10 to 20 years later. See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/28514">Rheumatic Heart Disease</ext-link>," for additional information regarding the presentation and long-term sequelae of rheumatic heart disease.</p>
        <p>Scarlet fever, caused by a delayed-type skin reactivity to an exotoxin produced by the organism, requires previous exposure and presents with 1- to 2-mm papular eruptions with a sandpaper-like feel. See StatPearls' companion reference, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/28741">Scarlet Fever</ext-link>," for additional information. PANDAS&#x000a0;occurs&#x000a0;in a subset of children whose symptoms of obsessive-compulsive disorder, tic disorders, or other neuropsychiatric symptoms like anxiety are exacerbated by GABS infection. PANDAS is a subset of pediatric acute-onset neuropsychiatric syndrome (PANS) thought sometimes to be brought on by various pathogens, including GABS.<xref ref-type="bibr" rid="article-27105.r50">[50]</xref> See StatPearls' additional companion references, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/30298">Toxic Shock Syndrome</ext-link>&#x000a0;and&#x000a0;<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/22287">Poststreptococcal Glomerulonephritis</ext-link>," for further information regarding these nonsuppurative complications of GABS pharyngitis.</p>
        <p>Pharyngeal sexually transmitted infections, such as gonorrhea and chlamydia, rarely cause complications, with 0.5% to 3% of all patients infected with <italic toggle="yes">N. gonorrhea</italic> in any location developing disseminated gonorrhea. Pharyngeal infections&#x000a0;are contagious,&#x000a0;increasing the risk of infection for sexual partners who can develop symptoms and cause complications like pelvic inflammatory disease, orchitis, and prostatitis.<xref ref-type="bibr" rid="article-27105.r51">[51]</xref></p>
        <p>Patients with diphtheria may experience respiratory compromise through swelling of the upper airway, cardiovascular compromise through toxin-induced myocarditis, renal failure, and local or systemic paralysis due to neurologic toxicity.<xref ref-type="bibr" rid="article-27105.r52">[52]</xref></p>
        <p>Potential complications associated with tularemia are&#x000a0;sepsis, renal failure, rhabdomyolysis, and hepatitis. Rarely,&#x000a0;<italic toggle="yes">F. tularensis</italic>&#x000a0;infection may cause otitis media and mastoiditis, endocarditis, pericarditis, myocarditis, meningitis, osteomyelitis, peritonitis, granulomatous hepatitis, spontaneous splenic rupture, and aortitis.<xref ref-type="bibr" rid="article-27105.r53">[53]</xref><xref ref-type="bibr" rid="article-27105.r54">[54]</xref>&#x000a0;</p>
        <p>Pharyngitis due to <italic toggle="yes">Y. pestis</italic>&#x000a0;hints at a potential site of inoculation&#x000a0;and may not represent&#x000a0;a typical initial presentation of plague. Patients who do not develop the typical bubos are challenging to diagnose and may develop meningitis, multiorgan failure, and death.<xref ref-type="bibr" rid="article-27105.r55">[55]</xref><xref ref-type="bibr" rid="article-27105.r56">[56]</xref></p>
      </sec>
      <sec id="article-27105.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Most infectious acute pharyngitis cases are due to respiratory viral pathogens, and symptomatic treatment alone is adequate. Information on supportive measures such as rest, hydration, and pain relief options can empower patients to manage their symptoms effectively. Patients can reduce the incidence of bacterial pharyngitis with proper hygiene protocols, such as handwashing, avoiding sharing food or beverages, and covering the mouth while coughing and sneezing.&#x000a0;</p>
        <p>Accurate identification of bacterial pharyngitis is critical to avoid unnecessary testing, treatment, and potential complications from untreated infections.&#x000a0;Avoiding&#x000a0;unnecessary antibiotic use and promoting patient education in bacterial pharyngitis management are essential roles for clinicians. Most cases of bacterial pharyngitis resolve spontaneously after 3 to 5 days. However,&#x000a0;bacterial pharyngitis should be treated with the appropriate antibiotics to prevent suppurative and nonsuppurative complications associated with GABS pharyngitis.</p>
        <p>Patients should know the potential complications of GABS pharyngitides, such as acute rheumatic fever, poststreptococcal glomerulonephritis, and retropharyngeal abscess, and&#x000a0;the symptoms that should prompt an immediate call to their healthcare professional. Healthcare&#x000a0;providers&#x000a0;must educate patients on the importance of adhering to the prescribed treatment regimens, completing the entire course of antibiotics, and avoiding sharing medications. Proper patient education can help prevent complications and recurrent infections and minimize the spread of antibiotic-resistant bacteria. Adults and children may return to work, school, or daycare 24 hours after beginning antibiotics.</p>
      </sec>
      <sec id="article-27105.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Pharyngitis, characterized by inflammation of the pharynx leading to a sore throat, often stems from noninfectious causes or viral respiratory pathogens. However, bacterial causes also present a significant risk due to potential complications. The risk of complications necessitates a comprehensive assessment to discern between common, uncommon, and life-threatening origins. Distinguishing between viral and bacterial pharyngitis may prove challenging as symptoms can overlap. Accurate recognition of bacterial pharyngitis is essential to prevent unnecessary tests and treatments, as well as potential complications from untreated infections.</p>
        <p>The initial history and physical examination help exclude life-threatening conditions and identify treatable causes of pharyngitis. Patients with bacterial pharyngitis are at risk for severe complications, and healthcare professionals caring for patients with acute pharyngitis must be adept at distinguishing between viral and bacterial causes.&#x000a0;</p>
        <p>Differentiating between viral and bacterial pharyngitis relies on clinical&#x000a0;evaluation and appropriate testing, such as that for GABS. The Centor criteria and other clinical decision rules assist in determining which adult patients warrant testing for GABS. Clinical decision rules are not reliable predictors for children with pharyngitis. Additionally, testing for other bacterial causes, such as sexually transmitted infections, may be necessary based on risk factors and symptoms.</p>
        <p>Physicians and advanced practitioners&#x000a0;utilize their clinical skills to accurately identify the condition, determine appropriate diagnostic tests, prescribe antibiotics when necessary, and manage potential complications. These healthcare professionals should use evidence-based guidelines, such as the Centor criteria, to guide testing and treatment decisions effectively.</p>
        <p>Nurses are crucial in patient education and support, ensuring correct sampling for rapid testing and bacterial cultures and facilitating communication between patients and other healthcare team members. Pharmacists also educate patients about antibiotic use, including dosage, frequency, and potential side effects, to promote adherence and minimize the development of antibiotic resistance. Clinicians reserve imaging for cases of clinical instability or suspected complications. By employing a comprehensive evaluation approach and appropriate diagnostic strategies, clinicians can accurately diagnose bacterial pharyngitis, tailor treatment effectively, and minimize the risk of complications.</p>
        <p>Interprofessional communication is essential for effective collaboration and coordination of care. Healthcare professionals must communicate efficiently and accurately to ensure patients receive timely and appropriate treatment. Team members must share relevant patient information, discuss treatment plans, and address concerns or questions during care. By leveraging their skills, implementing effective strategies, fostering interprofessional communication, and coordinating care, physicians, advanced practitioners, nurses, pharmacists, and other healthcare professionals can enhance patient-centered care, improve outcomes, promote patient safety, and optimize team performance in managing bacterial pharyngitis.</p>
      </sec>
      <sec id="article-27105.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27105&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27105">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27105/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27105">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27105.s15">
        <title>References</title>
        <ref id="article-27105.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shulman</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Bisno</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Clegg</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Gerber</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Van Beneden</surname>
                <given-names>C</given-names>
              </name>
              <collab>Infectious Diseases Society of America</collab>
            </person-group>
            <article-title>Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America.</article-title>
            <source>Clin Infect Dis</source>
            <year>2012</year>
            <month>Nov</month>
            <day>15</day>
            <volume>55</volume>
            <issue>10</issue>
            <fpage>e86</fpage>
            <page-range>e86-102</page-range>
            <pub-id pub-id-type="pmid">22965026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Renner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Shephard</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Environmental and non-infectious factors in the aetiology of pharyngitis (sore throat).</article-title>
            <source>Inflamm Res</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>61</volume>
            <issue>10</issue>
            <fpage>1041</fpage>
            <page-range>1041-52</page-range>
            <pub-id pub-id-type="pmid">22890476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalra</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Perez</surname>
                <given-names>ED</given-names>
              </name>
            </person-group>
            <article-title>Common Questions About Streptococcal Pharyngitis.</article-title>
            <source>Am Fam Physician</source>
            <year>2016</year>
            <month>Jul</month>
            <day>01</day>
            <volume>94</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-31</page-range>
            <pub-id pub-id-type="pmid">27386721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patton</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Kidd</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Llata</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Stenger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Braxton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Asbel</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gratzer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jespersen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kerani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mettenbrink</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pathela</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stirland</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stover</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tabidze</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kirkcaldy</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Weinstock</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Extragenital gonorrhea and chlamydia testing and infection among men who have sex with men--STD Surveillance Network, United States, 2010-2012.</article-title>
            <source>Clin Infect Dis</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>58</volume>
            <issue>11</issue>
            <fpage>1564</fpage>
            <page-range>1564-70</page-range>
            <pub-id pub-id-type="pmid">24647015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Plague gives surprises in the first decade of the 21st century in the United States and worldwide.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>89</volume>
            <issue>4</issue>
            <fpage>788</fpage>
            <page-range>788-93</page-range>
            <pub-id pub-id-type="pmid">24043686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galazka</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Diphtheria: changing patterns in the developing world and the industrialized world.</article-title>
            <source>Eur J Epidemiol</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-17</page-range>
            <pub-id pub-id-type="pmid">7489768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Boyle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barton</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>D'Aeth</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Cordery</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fry</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Litt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Southgate</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Verrecchia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mannes</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Olufon</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Dickinson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ramsay</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Amirthalingam</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>National public health response to an outbreak of toxigenic Corynebacterium diphtheriae among asylum seekers in England, 2022: a descriptive epidemiological study.</article-title>
            <source>Lancet Public Health</source>
            <year>2023</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>10</issue>
            <fpage>e766</fpage>
            <page-range>e766-e775</page-range>
            <pub-id pub-id-type="pmid">37777286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schappert</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Rechtsteiner</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Ambulatory medical care utilization estimates for 2006.</article-title>
            <source>Natl Health Stat Report</source>
            <year>2008</year>
            <month>Aug</month>
            <day>06</day>
            <issue>8</issue>
            <fpage>1</fpage>
            <page-range>1-29</page-range>
            <pub-id pub-id-type="pmid">18958997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andr&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Odenholt</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Schwan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Axelsson</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Eriksson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000f6;lstad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Runehagen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lundborg</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Wahlstr&#x000f6;m</surname>
                <given-names>R</given-names>
              </name>
              <collab>Swedish Study Group on Antibiotic Use</collab>
            </person-group>
            <article-title>Upper respiratory tract infections in general practice: diagnosis, antibiotic prescribing, duration of symptoms and use of diagnostic tests.</article-title>
            <source>Scand J Infect Dis</source>
            <year>2002</year>
            <volume>34</volume>
            <issue>12</issue>
            <fpage>880</fpage>
            <page-range>880-6</page-range>
            <pub-id pub-id-type="pmid">12587619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Danchin</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kelpie</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Selvaraj</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Carlin</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Nolan</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Carapetis</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Burden of acute sore throat and group A streptococcal pharyngitis in school-aged children and their families in Australia.</article-title>
            <source>Pediatrics</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>120</volume>
            <issue>5</issue>
            <fpage>950</fpage>
            <page-range>950-7</page-range>
            <pub-id pub-id-type="pmid">17974731</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varosy</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>TB</given-names>
              </name>
            </person-group>
            <article-title>Acute pharyngitis.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>May</month>
            <day>10</day>
            <volume>344</volume>
            <issue>19</issue>
            <fpage>1479; author reply 1480</fpage>
            <pub-id pub-id-type="pmid">11357847</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tibazarwa</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Volmink</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mayosi</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Incidence of acute rheumatic fever in the world: a systematic review of population-based studies.</article-title>
            <source>Heart</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>94</volume>
            <issue>12</issue>
            <fpage>1534</fpage>
            <page-range>1534-40</page-range>
            <pub-id pub-id-type="pmid">18669552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kogler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sadoghi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Draschl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chromy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schiefer-Niederkorn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hofmann-Wellenhof</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium at pharyngeal and anorectal sites in patients presenting to an STI outpatient ward.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2024</year>
            <month>Apr</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">38606611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carville</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Meagher</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Abo</surname>
                <given-names>YN</given-names>
              </name>
              <name>
                <surname>Manski-Nankervis</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Fielding</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Steer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McVernon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Burden of antimicrobial prescribing in primary care attributable to sore throat: a retrospective cohort study of patient record data.</article-title>
            <source>BMC Prim Care</source>
            <year>2024</year>
            <month>Apr</month>
            <day>17</day>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>117</fpage>
            <pub-id pub-id-type="pmid">38632513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fischetti</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>Streptococcal M protein.</article-title>
            <source>Sci Am</source>
            <year>1991</year>
            <month>Jun</month>
            <volume>264</volume>
            <issue>6</issue>
            <fpage>58</fpage>
            <page-range>58-65</page-range>
            <pub-id pub-id-type="pmid">1857955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevens</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Necrotizing Soft-Tissue Infections.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Dec</month>
            <day>07</day>
            <volume>377</volume>
            <issue>23</issue>
            <fpage>2253</fpage>
            <page-range>2253-2265</page-range>
            <pub-id pub-id-type="pmid">29211672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lottenberg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Broder</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Identification of a specific receptor for plasmin on a group A streptococcus.</article-title>
            <source>Infect Immun</source>
            <year>1987</year>
            <month>Aug</month>
            <volume>55</volume>
            <issue>8</issue>
            <fpage>1914</fpage>
            <page-range>1914-8</page-range>
            <pub-id pub-id-type="pmid">3038753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hurst</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Brouwer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Streptococcal superantigens and the return of scarlet fever.</article-title>
            <source>PLoS Pathog</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>12</issue>
            <fpage>e1010097</fpage>
            <pub-id pub-id-type="pmid">34969060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hughes-Games</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Direct visualization of sequence-specific DNA binding by gonococcal type IV pili.</article-title>
            <source>Microbiology (Reading)</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>168</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">35920810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yavlovich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tarshis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rottem</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells.</article-title>
            <source>FEMS Microbiol Lett</source>
            <year>2004</year>
            <month>Apr</month>
            <day>15</day>
            <volume>233</volume>
            <issue>2</issue>
            <fpage>241</fpage>
            <page-range>241-6</page-range>
            <pub-id pub-id-type="pmid">15063492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Fifteen-minute consultation: Group A streptococcal pharyngitis, diagnosis and treatment in children.</article-title>
            <source>Arch Dis Child Educ Pract Ed</source>
            <year>2024</year>
            <month>Sep</month>
            <day>19</day>
            <volume>109</volume>
            <issue>5</issue>
            <fpage>210</fpage>
            <page-range>210-221</page-range>
            <pub-id pub-id-type="pmid">38514137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chapel</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>The signs and symptoms of secondary syphilis.</article-title>
            <source>Sex Transm Dis</source>
            <year>1980</year>
            <season>Oct-Dec</season>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>161</fpage>
            <page-range>161-4</page-range>
            <pub-id pub-id-type="pmid">7455863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braun</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Huttner</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Schmid</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Mycoplasma pneumoniae: usual suspect and unsecured diagnosis in the acute setting.</article-title>
            <source>J Emerg Med</source>
            <year>2006</year>
            <month>May</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>371</fpage>
            <page-range>371-5</page-range>
            <pub-id pub-id-type="pmid">16740444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chakraborty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chandran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dhama</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gopinath</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jairath</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rialch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chaicumpa</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Saikumar</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Tularemia - a re-emerging disease with growing concern.</article-title>
            <source>Vet Q</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-16</page-range>
            <pub-id pub-id-type="pmid">37916743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crook</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Tempest</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Plague. A clinical review of 27 cases.</article-title>
            <source>Arch Intern Med</source>
            <year>1992</year>
            <month>Jun</month>
            <volume>152</volume>
            <issue>6</issue>
            <fpage>1253</fpage>
            <page-range>1253-6</page-range>
            <pub-id pub-id-type="pmid">1599354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ebell</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Barry</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Ives</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The rational clinical examination. Does this patient have strep throat?</article-title>
            <source>JAMA</source>
            <year>2000</year>
            <month>Dec</month>
            <day>13</day>
            <volume>284</volume>
            <issue>22</issue>
            <fpage>2912</fpage>
            <page-range>2912-8</page-range>
            <pub-id pub-id-type="pmid">11147989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haynes</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Temkit</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kushner</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hindman</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>Appropriateness of Use of Streptococcal Pharyngitis Testing and Associated Antibiotic Prescribing in the Urgent Care Setting.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>2024</year>
            <month>Mar</month>
            <day>12</day>
            <fpage>99228241237908</fpage>
            <pub-id pub-id-type="pmid">38469805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanagasabai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Hay</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Savovi&#x00107;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Elwenspoek</surname>
                <given-names>MMC</given-names>
              </name>
            </person-group>
            <article-title>Systematic review and meta-analysis of the accuracy of McIsaac and Centor score in patients presenting to secondary care with pharyngitis.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>445</fpage>
            <page-range>445-452</page-range>
            <pub-id pub-id-type="pmid">38182052</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fine</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Nizet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mandl</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Large-scale validation of the Centor and McIsaac scores to predict group A streptococcal pharyngitis.</article-title>
            <source>Arch Intern Med</source>
            <year>2012</year>
            <month>Jun</month>
            <day>11</day>
            <volume>172</volume>
            <issue>11</issue>
            <fpage>847</fpage>
            <page-range>847-52</page-range>
            <pub-id pub-id-type="pmid">22566485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Little</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hobbs</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mant</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Williamson</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>McNulty</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lasseter</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Leydon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pinedo-Villanueva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Raftery</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Glasziou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mullee</surname>
                <given-names>M</given-names>
              </name>
              <collab>PRISM investigators</collab>
            </person-group>
            <article-title>PRImary care Streptococcal Management (PRISM) study: in vitro study, diagnostic cohorts and a pragmatic adaptive randomised controlled trial with nested qualitative study and cost-effectiveness study.</article-title>
            <source>Health Technol Assess</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>vii</fpage>
            <page-range>vii-xxv, 1-101</page-range>
            <pub-id pub-id-type="pmid">24467988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roggen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>van Berlaer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gordts</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pierard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hubloue</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Centor criteria in children in a paediatric emergency department: for what it is worth.</article-title>
            <source>BMJ Open</source>
            <year>2013</year>
            <volume>3</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">23613571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thompson</surname>
                <given-names>TZ</given-names>
              </name>
              <name>
                <surname>McMullen</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Group A Streptococcus Testing in Pediatrics: the Move to Point-of-Care Molecular Testing.</article-title>
            <source>J Clin Microbiol</source>
            <year>2020</year>
            <month>May</month>
            <day>26</day>
            <volume>58</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">32161094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shulman</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Bisno</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Clegg</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Gerber</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Van Beneden</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America.</article-title>
            <source>Clin Infect Dis</source>
            <year>2012</year>
            <month>Nov</month>
            <day>15</day>
            <volume>55</volume>
            <issue>10</issue>
            <fpage>1279</fpage>
            <page-range>1279-82</page-range>
            <pub-id pub-id-type="pmid">23091044</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bolan</surname>
                <given-names>GA</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention</collab>
            </person-group>
            <article-title>Sexually transmitted diseases treatment guidelines, 2015.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2015</year>
            <month>Jun</month>
            <day>05</day>
            <volume>64</volume>
            <issue>RR-03</issue>
            <fpage>1</fpage>
            <page-range>1-137</page-range>
            <pub-id pub-id-type="pmid">26042815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galioto</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Peritonsillar Abscess.</article-title>
            <source>Am Fam Physician</source>
            <year>2017</year>
            <month>Apr</month>
            <day>15</day>
            <volume>95</volume>
            <issue>8</issue>
            <fpage>501</fpage>
            <page-range>501-506</page-range>
            <pub-id pub-id-type="pmid">28409615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gehanno</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dreiser</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Ionescu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Lowest effective single dose of diclofenac for antipyretic and analgesic effects in acute febrile sore throat.</article-title>
            <source>Clin Drug Investig</source>
            <year>2003</year>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>263</fpage>
            <page-range>263-71</page-range>
            <pub-id pub-id-type="pmid">17535039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Myrex</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Tonsillitis and Tonsilloliths: Diagnosis and Management.</article-title>
            <source>Am Fam Physician</source>
            <year>2023</year>
            <month>Jan</month>
            <volume>107</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-41</page-range>
            <pub-id pub-id-type="pmid">36689967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bachmann</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Muzny</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Reno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zenilman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bolan</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Sexually Transmitted Infections Treatment Guidelines, 2021.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2021</year>
            <month>Jul</month>
            <day>23</day>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>1</fpage>
            <page-range>1-187</page-range>
            <pub-id pub-id-type="pmid">34292926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eisenberg</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Panunzi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Wolz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Burzio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cilliers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Noor</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Jalon</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Jannat-Khah</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gil Cuesta</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Diphtheria Antitoxin Administration, Outcomes, and Safety: Response to a Diphtheria Outbreak in Cox's Bazar, Bangladesh.</article-title>
            <source>Clin Infect Dis</source>
            <year>2021</year>
            <month>Oct</month>
            <day>05</day>
            <volume>73</volume>
            <issue>7</issue>
            <fpage>e1713</fpage>
            <page-range>e1713-e1718</page-range>
            <pub-id pub-id-type="pmid">33245364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farizo</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Strebel</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Kimbler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cleary</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Cochi</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control.</article-title>
            <source>Clin Infect Dis</source>
            <year>1993</year>
            <month>Jan</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-68</page-range>
            <pub-id pub-id-type="pmid">8448320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kadri</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Swihart</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Bonne</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Hohmann</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Hennessy</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Louras</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Rhee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Suffredini</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Hooper</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Follmann</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Bulger</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Danner</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>Apr</month>
            <day>01</day>
            <volume>64</volume>
            <issue>7</issue>
            <fpage>877</fpage>
            <page-range>877-885</page-range>
            <pub-id pub-id-type="pmid">28034881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Madsen</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Hjortrup</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Lange</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Norrby-Teglund</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hyldegaard</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Perner</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial.</article-title>
            <source>Intensive Care Med</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>43</volume>
            <issue>11</issue>
            <fpage>1585</fpage>
            <page-range>1585-1593</page-range>
            <pub-id pub-id-type="pmid">28421246</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbee</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Soge</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Khosropour</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Haglund</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Golden</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>The Duration of Pharyngeal Gonorrhea: A Natural History Study.</article-title>
            <source>Clin Infect Dis</source>
            <year>2021</year>
            <month>Aug</month>
            <day>16</day>
            <volume>73</volume>
            <issue>4</issue>
            <fpage>575</fpage>
            <page-range>575-582</page-range>
            <pub-id pub-id-type="pmid">33513222</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>WANNAMAKER</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>RAMMELKAMP</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>DENNY</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>BRINK</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>HOUSER</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>HAHN</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>DINGLE</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin.</article-title>
            <source>Am J Med</source>
            <year>1951</year>
            <month>Jun</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>673</fpage>
            <page-range>673-95</page-range>
            <pub-id pub-id-type="pmid">14837911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koirala</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Plague: disease, management, and recognition of act of terrorism.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>273</fpage>
            <page-range>273-87, viii</page-range>
            <pub-id pub-id-type="pmid">16762739</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kadirova</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kartoglu</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Strebel</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995.</article-title>
            <source>J Infect Dis</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>181 Suppl 1</volume>
            <fpage>S110</fpage>
            <page-range>S110-5</page-range>
            <pub-id pub-id-type="pmid">10657201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campbell</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Plague in India: a new warning from an old nemesis.</article-title>
            <source>Ann Intern Med</source>
            <year>1995</year>
            <month>Jan</month>
            <day>15</day>
            <volume>122</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-3</page-range>
            <pub-id pub-id-type="pmid">7992992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhavsar</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Group A Streptococcus Infections.</article-title>
            <source>Pediatr Rev</source>
            <year>2024</year>
            <month>Mar</month>
            <day>01</day>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>143</fpage>
            <page-range>143-151</page-range>
            <pub-id pub-id-type="pmid">38425166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bathala</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eccles</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A review on the mechanism of sore throat in tonsillitis.</article-title>
            <source>J Laryngol Otol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>127</volume>
            <issue>3</issue>
            <fpage>227</fpage>
            <page-range>227-32</page-range>
            <pub-id pub-id-type="pmid">23317998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gagliano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tanca</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Sotgiu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives.</article-title>
            <source>Neuropsychiatr Dis Treat</source>
            <year>2023</year>
            <volume>19</volume>
            <fpage>1221</fpage>
            <page-range>1221-1250</page-range>
            <pub-id pub-id-type="pmid">37251418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eschenbach</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Buchanan</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Pollock</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Forsyth</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Wentworth</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>MacCormack</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Polymicrobial etiology of acute pelvic inflammatory disease.</article-title>
            <source>N Engl J Med</source>
            <year>1975</year>
            <month>Jul</month>
            <day>24</day>
            <volume>293</volume>
            <issue>4</issue>
            <fpage>166</fpage>
            <page-range>166-71</page-range>
            <pub-id pub-id-type="pmid">806017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dobie</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Tobey</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>Clinical features of diphtheria in the respiratory tract.</article-title>
            <source>JAMA</source>
            <year>1979</year>
            <month>Nov</month>
            <day>16</day>
            <volume>242</volume>
            <issue>20</issue>
            <fpage>2197</fpage>
            <page-range>2197-201</page-range>
            <pub-id pub-id-type="pmid">490806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kara</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Polat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Erdeniz</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Donmez</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Pediatric Oropharyngeal Tularemia Cases: Challenges in Management.</article-title>
            <source>Vector Borne Zoonotic Dis</source>
            <year>2024</year>
            <month>Sep</month>
            <volume>24</volume>
            <issue>9</issue>
            <fpage>585</fpage>
            <page-range>585-590</page-range>
            <pub-id pub-id-type="pmid">38651622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abalos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cutrona</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Lessons Learned From a Young Lady With a Bad Sore Throat.</article-title>
            <source>Am J Med</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>134</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-56</page-range>
            <pub-id pub-id-type="pmid">32505702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Welty</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Grabman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kompare</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Welty</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Van Duzen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rudd</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Poland</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Nineteen cases of plague in Arizona. A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy.</article-title>
            <source>West J Med</source>
            <year>1985</year>
            <month>May</month>
            <volume>142</volume>
            <issue>5</issue>
            <fpage>641</fpage>
            <page-range>641-6</page-range>
            <pub-id pub-id-type="pmid">4013279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27105.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arbaji</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kharabsheh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Al-Azab</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Al-Kayed</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Amr</surname>
                <given-names>ZS</given-names>
              </name>
              <name>
                <surname>Abu Baker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>A 12-case outbreak of pharyngeal plague following the consumption of camel meat, in north-eastern Jordan.</article-title>
            <source>Ann Trop Med Parasitol</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>99</volume>
            <issue>8</issue>
            <fpage>789</fpage>
            <page-range>789-93</page-range>
            <pub-id pub-id-type="pmid">16297292</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
